Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|January 21, 2015
Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric populationRebecca Venables, Hannah Batchelor, James Hodson, et al.
Archives of Disease in Childhood|August 20, 2016
COMPARISON OF HYDROCORTISONE 10 MG TABLETS: TABLET HARDNESS OPTIMISED FOR ADULT USE HAS NEGATIVE CONSEQUENCES FOR PAEDIATRIC USESarina Saimbi, Valerie Madden, Heather Stirling, et al.
Archives of Disease in Childhood|August 20, 2016
ASSESSMENT OF VANCOMYCIN CONCENTRATIONS IN SYRINGES PREPARED WITHIN A WARD SETTINGSarina Saimbi, Hannah Batchelor, Louise Whitticase, et al.
Archives of Disease in Childhood|August 20, 2016
CHILDREN WITH CYSTIC FIBROSIS: UNDERSTANDING ISSUES RELATED TO ORAL ADMINISTRATION OF LIQUID FLUCLOXACILLINHannah Batchelor, Oli Rayner, Jessica Nickless, et al.
Drug Development and Industrial Pharmacy|May 30, 2012
Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersionsSheraz Khan, Hannah Batchelor, Peter Hanson, et al.
International Journal of Pharmaceutics|June 29, 2016
Towards the development of a paediatric biopharmaceutics classification system: Results of a survey of expertsHannah Batchelor, Terry Ernest, Talia Flanagan, et al.
International Journal of Pharmaceutics|April 30, 2018
How close is the dose? Manipulation of 10 mg hydrocortisone tablets to provide appropriate doses to childrenCameron Watson, Emma A Webb, Stephanie Kerr, et al.
AAPS Pharmscitech|July 17, 2016
European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for ChildrenSmita Salunke, Fang Liu, Hannah Batchelor, et al.
International Journal of Pharmaceutics|March 19, 2022
Practical and operational considerations related to paediatric oral drug formulation: An industry surveyMatthias Van der Veken, Joachim Brouwers, Valérie Budts, et al.
Pageof 5